Strategic Vision for Rare Diseases: AI & Collaborative Approach Accelerating Diagnosis

Nov 21, 2024 — 10:55 am CET - 11:25 AM CET
MAINSTAGE

Presented by

Corinne Blachier Poisson

President France

Prof. Anita Burgun

Institute Imagine

Associate Researcher

Thibaud Guymard

Head of Innovation, Services & Digital

Virginie Lasserre

Johnson & Johnson Innovative Medicine

External Affairs Director

François Macary

Semantic interoperability expert

Solange Roumengous

French National Database of Rare...

Head of Industrial Partnerships

Description

This session will be in French

Presented by

Corinne Blachier Poisson

President France

Prof. Anita Burgun

Associate Researcher

Thibaud Guymard

Head of Innovation, Services & Digital

Virginie Lasserre

External Affairs Director

François Macary

Semantic interoperability expert

Solange Roumengous

Head of Industrial Partnerships

In partnership with

Suggested sessions

9:50 am CET - 10:00 am CET

Leveraging Data Science Community Power to Accelerate AI Adoption in Healthcare

In this session, we will explore how Trustii.io, a collaborative data science platform, is accelerating the adoption of AI in healthcare by connecting healthcare...

Prof. Antoine Roux

10:00 am CET - 10:10 am CET

Unlock Advanced Insights in ADLIN's Digital Research Environment with the Power of Generative AI

ADLIN Science is a pioneering French deeptech startup driving innovation at the intersection of life sciences, healthcare, and AI. Our mission is to empower...

Senior Data Scientist

Alexandra Bomane

Bioinformatician

10:10 am CET - 10:20 am CET

AI Models, Why Data Quality Matters

Health data quality is essential for the accuracy and reliability of AI models in healthcare, impacting patient safety and outcomes. Poor-quality data can lead to...

10:20 am CET - 10:30 am CET

Building a Generative AI Platform to Unlock the Power of Scientific Literature in Healthcare

In a world where scientific discoveries are rapidly multiplying, accessing and analyzing the immense amount of medical research becomes a real challenge. Opscidia uses...